418 related articles for article (PubMed ID: 9866434)
1. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State.
Frick PA; Black DJ; Duchin JS; Deliganis S; McKee WM; Fritsche TR
West J Med; 1998 Dec; 169(6):364-9. PubMed ID: 9866434
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.
Hofmann J; Cetron MS; Farley MM; Baughman WS; Facklam RR; Elliott JA; Deaver KA; Breiman RF
N Engl J Med; 1995 Aug; 333(8):481-6. PubMed ID: 7623880
[TBL] [Abstract][Full Text] [Related]
3. Drug-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Australian Group on Antimicrobial Resistance (AGAR).
Collignon PJ; Bell JM
Med J Aust; 1996 Jan; 164(2):64-7. PubMed ID: 8569573
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic susceptibility of invasive Streptococcus pneumoniae in Wisconsin, 1999.
Belongia EA; Proctor M; Vandermause M; Ahrabi-Fard S; Knobloch MJ; Keller P; Bergs R; Chyou PH; Davis JP
WMJ; 2000 Aug; 99(5):55-9. PubMed ID: 11043072
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of susceptibility status of invasive pneumococcal isolates to various antibiotics and risk factors associated with invasive penicillin-nonsusceptible pneumococcal infection: Bangkok 1997-1998.
Chokephaibulkit K; Srifuengfung S; Mingbanjerdsuk J; Tosasuk K; Vanprapar N; Chearskul S; Dhiraputra C
Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):498-505. PubMed ID: 11289009
[TBL] [Abstract][Full Text] [Related]
6. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
Whitney CG; Farley MM; Hadler J; Harrison LH; Lexau C; Reingold A; Lefkowitz L; Cieslak PR; Cetron M; Zell ER; Jorgensen JH; Schuchat A;
N Engl J Med; 2000 Dec; 343(26):1917-24. PubMed ID: 11136262
[TBL] [Abstract][Full Text] [Related]
7. Surveillance for penicillin-nonsusceptible Streptococcus pneumoniae--New York City, 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Apr; 46(14):297-9. PubMed ID: 9132581
[TBL] [Abstract][Full Text] [Related]
8. A significant increase in antimicrobial resistance among pneumococci causing invasive disease in New Zealand.
Brett MS; Martin DR
N Z Med J; 1999 Apr; 112(1085):113-5. PubMed ID: 10326798
[TBL] [Abstract][Full Text] [Related]
9. The approach to treatment of invasive pneumococcal disease in the 1990s.
Knapp KM; Schutze GE
J Ark Med Soc; 1997 Nov; 94(6):263-6. PubMed ID: 9392928
[TBL] [Abstract][Full Text] [Related]
10. Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococccal isolates in Asturias, Spain.
García-Suárez Mdel M; Villaverde R; Caldevilla AF; Méndez FJ; Vázquez F
Jpn J Infect Dis; 2006 Oct; 59(5):299-05. PubMed ID: 17060695
[TBL] [Abstract][Full Text] [Related]
11. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
[TBL] [Abstract][Full Text] [Related]
12. [Pneumococcal antibiotic resistance].
Moreillon P; Wenger A; Caldelari I
Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
[TBL] [Abstract][Full Text] [Related]
13. [Resistance to Streptococcus pneumoniae to penicillin and its association with clinical and epidemiological factors].
Contreras L; Fica A; Figueroa O; Enríquez N; Urrutia P; Herrera P
Rev Med Chil; 2002 Jan; 130(1):26-34. PubMed ID: 11961958
[TBL] [Abstract][Full Text] [Related]
14. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003.
Adegbola RA; Hill PC; Secka O; Ikumapayi UN; Lahai G; Greenwood BM; Corrah T
Trop Med Int Health; 2006 Jul; 11(7):1128-35. PubMed ID: 16827713
[TBL] [Abstract][Full Text] [Related]
15. Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology.
Poulakou G; Katsarolis I; Matthaiopoulou I; Tsiodras S; Kanavaki S; Hatzaki D; Roilides E; Sofianou D; Kavaliotis I; Kansouzidou A; Kafetzis DA; Paraskakis I; Foustoukou M; Daikos GL; Syriopoulou V; Pangalis A; Leveidiotou S; Giamarellou H;
Int J Antimicrob Agents; 2007 Jul; 30(1):87-92. PubMed ID: 17540542
[TBL] [Abstract][Full Text] [Related]
16. Serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae isolated from hospitalized patients in Thailand.
Srifeungfung S; Chokephaibulkit K; Tribuddharat C
Southeast Asian J Trop Med Public Health; 2007 May; 38(3):469-77. PubMed ID: 17877221
[TBL] [Abstract][Full Text] [Related]
17. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
[TBL] [Abstract][Full Text] [Related]
18. A description of antimicrobial susceptibility of Streptococcus pneumoniae-Siriraj Hospital, Thailand: 2008.
Srifuengfung S; Chokephaibulkit K; Tribuddharat C; Comerungsee S
J Med Assoc Thai; 2010 Nov; 93 Suppl 5():S27-34. PubMed ID: 21294379
[TBL] [Abstract][Full Text] [Related]
19. Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy.
Serrano I; Ramirez M; Melo-Cristino J;
Clin Microbiol Infect; 2004 Jul; 10(7):652-6. PubMed ID: 15214879
[TBL] [Abstract][Full Text] [Related]
20. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
Picazo JJ
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
